Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
Recruiting · NCT06705686 · Registry updated 2026-03-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 | 2026-03-20 | NCT06705686 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| TechnoGenesys, Inc. | 1 |
| University of Wisconsin, Madison | 265 |
| Washington University School of Medicine | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect | Madison | United States | 1 |